Cinctive Capital Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,019
Closed -$555K 515
2025
Q4
$555K Sell
34,019
-10,084
-23% -$152K 0.03% 326
2025
Q3
$516K Buy
+44,103
New +$575K 0.03% 344
2025
Q1
Sell
-24,479
Closed -$352K 472
2024
Q4
$352K Sell
24,479
-138,106
-85% -$2.18M 0.02% 329
2024
Q3
$3.67M Buy
+162,585
New +$3.36M 0.21% 168
2024
Q2
Sell
-13,234
Closed -$497K 539
2024
Q1
$497K Sell
13,234
-77,286
-85% -$3.4M 0.03% 343
2023
Q4
$5.07M Buy
+90,520
New +$3.94M 0.35% 103
2023
Q3
Sell
-71,948
Closed -$4.02M 502
2023
Q2
$4.02M Sell
71,948
-81,778
-53% -$4.43M 0.16% 218
2023
Q1
$8.58M Buy
+153,726
New +$7.18M 0.32% 116
2022
Q4
Sell
-18,788
Closed -$535K 557
2022
Q3
$535K Sell
18,788
-23,267
-55% -$886K 0.02% 384
2022
Q2
$1.9M Buy
+42,055
New +$2.18M 0.09% 316
2021
Q2
Sell
-12,471
Closed -$2.26M 623
2021
Q1
$2.26M Buy
+12,471
New +$2.15M 0.14% 249

Other funds holding TXG